definiens: shall mean theW - eatment or prevention of a diseas~ by means o ® x Vivo or In Vivo delivery ( via viral or nonviral gene transfer systems ) of . compositio~ comprising either ( aifJenetic Material that encodes an AntibodYJwherein such6 : ntibody ~rves a material functio~ the treatment.o ~ evention of such disease, ( b){genetic Materi ~ that Fncodes a moi~ other than ~ AntibodY, dwherein the it0iety serves a material functi ~ in the treatment or lention ot'such disease and wherem s""h [ composition incorporates an AntibodYj(or netic Materi;n thatincod ~ uch(Antibodll which ~tibodYl!s ~ as a . ~geting . vehicle for the co ~ positi0liJor ( c ) 12enetlc Mat ~ rialJthatEnc<>?~an ~ti~<!li that serves a rien function m the treatment of prevention of such disease wherem such composition also[ncorpora es d ~tibod ~ orlQenetic Materi~€ncod ~ such ~tibo~ which ~ ti dUis used as targetmg vehic e or the€'0mPQsition . used in this Section 5.5, ( i ) E'Ex Vivo " deliv ~ eh mean the[fntr uction, outsid ~ of th body}>f a hum~ of such [ compositio~ into a cel~ tissu~_~rganoidJ or ~g8:!il which contams such untroduced compositio ~ into th r dYJ'f the ezwe ( autologous ~ r ~ ifferent ( allogenei ~ human, without 46990~ vllIPA @2kvllLDOC 12199912210 t : J = CONFIDENTIAl TRE/.'TMENT REQUESTED EXECUTION COpy limitation as to the [ formulation, anatomic sit~ orrrou ;, } ofIadministratio ~ o. d ~ liv ~ ryjshall mean the [ fntr ~ ductlortjof . su~~omposltlons tnt ? . an n.ndlvld ~ j wIthout hmltatto~ as to the ITorm ~ tlon, anatoIDl . C Slte : l ~ U ~ O adnnmstrall05 or the use offncapsulallOi!lor other ~evicel for such fdministration ..